Table 4 Differences in pre-treatment characteristics, treatment details, post-treatment symptoms between those who did not need further treatment at EOT and those who needed in 52 female adolescents received FBT for AN

Age (years), mean (SD)

14.73(1.28

14.33(1.32)

p = 0.29

Pre-treatment %EBW, mean (SD)

80.72 (7.19)

84.81 (9.20)

p = 0.09

Duration of AN (months), mean (SD)

12.59 (6.75)

13.80 (9.11)

p = 0.60

Psychiatric comorbidity, n (%)

2 (9.1%)

12 (40.0%)

X²(df) = 6.163(1)^**, p = 0.01 φ = 0.34

Psychopharmacological treatment, n (%)

2 (9.1%)

13 (43.3%)

X²(df) = 7.250(1)^**, p < 0.001φ = 0.37

Previous treatment for AN, n (%)

3 (13.6%)

14 (46.7%)

X²(df) = 6.293(1)^**, p = 0.01 φ = 0.35

%EBW at EOT,mean (SD)

98.74 (9.87)

98.59 (11.86)

p = 0.96

Weight gain,mean (SD)

10.90 (4.53)

7.52 (3.99)

t(df) = 2.844(50)^*, p < 0.001 φ = 0.79

Depression symptoms at EOT, n (%)

1 (4,5%)

11 (36.7%)

X²(df) = 7.381(1)^**, p < 0.001φ = 0.38

Anxiety at EOT, n (%)

1 (4.5%)

22 (73.3%)

X²(df) = 24.350(1)^**, p < 0.001 φ = 0.68

Dietary restrictions at EOT, n (%)

0 (0%)

12 (40.0%)

X²(df) = 10.991(1)^*, p < 0.001 φ = 0.46

Appearance dissatisfaction at EOT,n (%)

1 (4.5%)

12 (40.0%)

X²(df) = 9.902(1)^*, p < 0.001φ = 0.45

Fear of gaining weight at EOT, n (%)

0 (0%)

11 (36.7%)

X²(df) = 13.252(1)^*, p < 0.001φ = 0.54

Body image distortion at EOT, n (%)

0 (0%)

6 (20.0%)

X²(df) = 6.621(1)^**, p = 0.01φ = 0.38